Skip to main content
SpringerLink
Log in

Estrogen/Hormone Replacement Therapy and the Etiology of Breast Cancer

  • Conference paper
Adjuvant Therapy of Primary Breast Cancer VI

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 152))

Abstract

There have been many analyses of the association between the use of estrogen/hormone replacement therapy (ERT/HRT) and the development of breast cancer. Most data are derived from observational studies, however, and although interventional studies are underway, no data from them are as yet available. As ERT/HRT is increasingly studied, some issues are becoming quite clear while others remain more difficult to elucidate. In this paper, the term estrogen replacement therapy (ERT) is used to refer to estrogen used alone, while combined therapy or hormone replacement therapy (HRT) refers to an estrogen given together with a progestational.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bonnier P, Romain S, Giacalone PL (1995) Clinical and biologic prognostic factors in breast cancer diagnosed during postmenopausal hormone replacement therapy. Obstet Gynecol 85:11–17

    Article  PubMed  CAS  Google Scholar 

  • Calle EE, Miracle-McMahill HL, Thun MJ, Heath CW (1995) Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women. J Natl Cancer Inst 87:517–523

    Article  PubMed  CAS  Google Scholar 

  • Cauley JA, Seeley DG, Ensrud K, Ettinger B, Black D, Cummings SR (1995) Estrogen replacement therapy and fractures in older women. Ann Inter Med 122:9–16

    CAS  Google Scholar 

  • Colditz GA, Egan KM, Stampfer MJ (1993) Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies. Am J Obstet Gynecol 168:1473–1480

    PubMed  CAS  Google Scholar 

  • Colditz GA, Rosner B, Speizer FE (1996). Risk factors for breast cancer according to family history of breast cancer. For the Nurses Health Study Research Group. J Natl Cancer Inst 99:365–371

    Google Scholar 

  • Delmas PD, Bjarnason NH, Mitlak BH, Ravoux AC, Shah AS, Huster, WJ, Draper M, Christiansen C (1997) Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med 337:1641–1647

    Article  PubMed  CAS  Google Scholar 

  • Eden JA (1991) Progestogens: an occasional review. J Obstet Gynecol 17:289–295

    CAS  Google Scholar 

  • Falkeborn M, Persson I, Adami HO, Bergstrom R, Eaker E, Lithell H, Mohsen R, Naessen T (1992) The risk of acute myocardial infarction after estrogen and estrogen-progestogen replacement. Br J Obstet Gynaecol 99:821–828

    Article  PubMed  CAS  Google Scholar 

  • Grady D, Ernster VL (1997) Hormone replacement therapy and endometrial cancer: are current regimens safe? J Natl Cancer Inst 89:1088–1089

    Article  PubMed  CAS  Google Scholar 

  • Grady D, Cummings SR, Petitti D, Rubin SM, Audet AM (1992a) Guidelines for counselling postmenopausal women about preventive hormone therapy. Ann Intern Med 117:1038–1041

    Google Scholar 

  • Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR (1992b) Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 117:1016–1037

    PubMed  CAS  Google Scholar 

  • Grodstein F, Stampfer M., Colditz GA, Willett WC, Manson JE, Joffe M, Rosner B, Fuchs C, Hankinson SE, Hunter DJ, Hennekens CH, Speizer FE (1997) Postmenopausal hormone therapy and mortality. N Eng J Med 336:1769–1775

    Article  CAS  Google Scholar 

  • Harding C, Knox WF, Faragher EB (1996) Hormone replacement therapy and tumour grade in breast cancer: prospective study in a screening unit. Br Med J 312:1646–1647

    Article  CAS  Google Scholar 

  • Hosking D, Chilvers CED, Christiansen C, Ravn P, Wasnich R, Ross P, McClung M, Balske A, Thompson D, Daley M, Yates AJ (1998) Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. N Engl J Med 338:485–492

    Article  PubMed  CAS  Google Scholar 

  • Kawas C, Resnick S, Morrison A, Brookmeyer R, Corrada M, Zonderman A, Bacal C, Lingle DD, Metter E (1997) A prospective study of estrogen replacement therapy and the risk of developing Alzheimer’s disease: the Baltimore Longitudinal Study of Aging. Neurology 48:1517–1521

    PubMed  CAS  Google Scholar 

  • Laya MB, Larson EB, Taplin SH, White E (1996) Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography. Natl Cancer Inst 88:643–649

    Article  CAS  Google Scholar 

  • Lobo BA (1991) Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women. J Clin Endocrinol Metab 73:925–931

    Article  PubMed  CAS  Google Scholar 

  • Lufkin EG, Warmer HW, O’Fallon WM, Hodgson SF, Kotowicz MA, Lane AW, Judd HL, Caplan RH, Riggs BL (1992) Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med 117:1–9

    PubMed  CAS  Google Scholar 

  • Nabulsi MB, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M (1993) Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 328:1069–1075

    Article  PubMed  CAS  Google Scholar 

  • Norlock FE, Oleske DM, Cobleigh MA (1998) Hormone replacement therapy use correlates with high S-phase in estrogen-receptor-positive primary human breast cancer. Proc Am Soc Clin Oncol 17:109a

    Google Scholar 

  • Paganini-Hill A, Henderson VW (1996) Estrogen replacement therapy and risk of Alzheimer disease. Arch Intern Med 156:2213–2217

    Article  PubMed  CAS  Google Scholar 

  • PEPI Trial (1995) Effects of estrogen or estrogen/progestin regimes on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. JAMA 273:199–208

    Article  Google Scholar 

  • Pike MC, Peters RK, Cozen W, Probst-Hensch NM (1997) Estrogen-progestin replacement therapy and endometrial cancer. J Natl Cancer Inst 89:1110–1116

    Article  PubMed  CAS  Google Scholar 

  • Psaty BM, Heckbert SR, Atkins D, Lemaitre R, Koepsell TD, Wahl PW, Siscovick DS, Wagner EH (1994) The risk of myocardial infarction associated with the combined use of estrogen and progestins in postmenopausal women. Arch Intern Med 154:1333–1339

    Article  PubMed  CAS  Google Scholar 

  • Sillero-Arenas M, Delgado-Rodriguez M, Rodigues-Canteras R, Bueno-Cavanillas A, Galvez-Vargas R (1992) Menopausal hormone replacement therapy and breast cancer: a meta-analysis. Obstet Gynecol 79:286–294

    PubMed  CAS  Google Scholar 

  • Steinberg KK, Thacker SB, Smith SJ, Stroup DF, Zack MM, Flanders D, Berkelman RL (1991) A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA 265:1985–1990

    Article  PubMed  CAS  Google Scholar 

  • Steinberg KK, Smith SJ, Thacker SB, Stroup DF (1994) Breast cancer risk and duration of estrogen use: the role of study design in meta-analysis. Epidemiology 5:415–421

    Article  PubMed  CAS  Google Scholar 

  • Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland P, Andrews H, Mayeux R (1996) Effect of estrogen during menopause on risk and age at onset of Alzheimer’s disease. Lancet 348:429–432

    Article  PubMed  CAS  Google Scholar 

  • Weiss NS, Ure CL, Ballard SH, Williams AR, Daling SR (1980) Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med 303:1195–1198

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Oncology, Sunnybrook Health Science Center, Bayview Regional Cancer Center, 2075 Bayview Avenue, Toronto, M4N 3M5, Canada

    K. I. Pritchard

Authors
  1. K. I. Pritchard
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Zentrum für Tumordiagnostik und Prävention, Rorschacherstrasse 150, CH-9006, St. Gallen, Switzerland

    Hans-Jörg Senn

  2. Dana Farber Cancer Institute Biostatistics, 44 Binney Street, Boston, 02115, USA

    Richard D. Gelber Ph.D

  3. Ospedale Civico, CH-6900, Lugano, Switzerland

    Aron Goldhirsch

  4. Klinik C für Innere Medizin Abteilung für Onkologie und Hämatologie, Kantonsspital St. Gallen, CH-9007, St. Gallen, Switzerland

    Beat Thürlimann

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin · Heidelberg

About this paper

Cite this paper

Pritchard, K.I. (1998). Estrogen/Hormone Replacement Therapy and the Etiology of Breast Cancer. In: Senn, HJ., Gelber, R.D., Goldhirsch, A., Thürlimann, B. (eds) Adjuvant Therapy of Primary Breast Cancer VI. Recent Results in Cancer Research, vol 152. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-45769-2_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-45769-2_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-45771-5

  • Online ISBN: 978-3-642-45769-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation